Unicycive Therapeutics, Inc. (UNCY) Ownership

Unicycive Therapeutics, Inc. (UNCY) Ownership

NASDAQ Currency in USD Disclaimer

Stock Price

$0.71

-$0.03

(-3.45%)

Day's range
$0.7
Day's range
$0.76

Unicycive Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
GREAT POINT PARTNERS LLC 11/13/2024 8.56 M $3.49 B   100.00% 9.62%
OCTAGON CAPITAL ADVISORS LP 11/14/2024 8.56 M $3.49 M   100.00% 9.62%
LOGOS GLOBAL MANAGEMENT LP 11/14/2024 5.08 M $2.07 M   46.37% 5.71%
WALLEYE CAPITAL LLC 11/14/2024 5.00 M $2.04 M   100.00% 5.62%
VIVO CAPITAL, LLC 11/13/2024 4.47 M $1.82 M   28.82% 5.03%
SILVERARC CAPITAL MANAGEMENT, LLC 11/14/2024 4.00 M $1.63 M   100.00% 4.50%
NANTAHALA CAPITAL MANAGEMENT, LLC 11/14/2024 2.82 M $1.15 M   0.00% 3.17%
ALYESKA INVESTMENT GROUP, L.P. 11/14/2024 2.25 M $917,775   100.00% 2.53%
ACUTA CAPITAL PARTNERS, LLC 11/14/2024 1.98 M $807,315   100.00% 2.23%
ALTIUM CAPITAL MANAGEMENT LP 11/14/2024 1.47 M $600,837   100.00% 1.66%
VANGUARD GROUP INC 11/13/2024 1.14 M $464,394   0.00% 1.28%
LPL FINANCIAL LLC 11/08/2024 466,005 $190,083   448.24% 0.52%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 402,398 $164,138   40.83% 0.45%
GOLDMAN SACHS GROUP INC 11/14/2024 93,424 $38,108   0.08% 0.11%
BLEAKLEY FINANCIAL GROUP, LLC 10/16/2024 80,000 $32,632   100.00% 0.09%
VIRTU FINANCIAL LLC 11/20/2024 73,975 $30,000   566.80% 0.08%
BLACKROCK FUNDING, INC. /DE 11/13/2024 71,821 $29,296   100.00% 0.08%
XTX TOPCO LTD 11/14/2024 70,784 $28,873   100.00% 0.08%
STATE STREET CORP 11/14/2024 43,936 $17,921   0.00% 0.05%
JANE STREET GROUP, LLC 11/15/2024 41,249 $16,826   100.00% 0.05%
TWO SIGMA SECURITIES, LLC 11/14/2024 23,266 $9,490   100.00% 0.03%
TOWER RESEARCH CAPITAL LLC (TRC) 11/14/2024 22,782 $9,295   23.25% 0.03%
CAPTRUST FINANCIAL ADVISORS 11/14/2024 18,800 $7,669   0.00% 0.02%
TANDEM CAPITAL MANAGEMENT CORP /ADV 10/25/2024 15,500 $6,322   0.00% 0.02%
CREATIVE PLANNING 10/11/2024 10,231 $4,173   100.00% 0.01%
BANK OF AMERICA CORP /DE/ 11/14/2024 332 $135   48.88% 0.00%
JPMORGAN CHASE & CO 11/08/2024 207 $84   195.71% 0.00%
RENAISSANCE TECHNOLOGIES LLC 11/13/2024 0 $0   -100.00% 0.00%
BVF INC/IL 11/14/2024 0 $0   -100.00% 0.00%
RA CAPITAL MANAGEMENT, L.P. 11/14/2024 0 $0   -100.00% 0.00%
UBS GROUP AG 11/14/2024 0 $0   -100.00% 0.00%
ROSALIND ADVISORS, INC. 10/30/2024 0 $0   -100.00% 0.00%
MONASHEE INVESTMENT MANAGEMENT LLC 11/12/2024 0 $0   -100.00% 0.00%
REDWOOD WEALTH MANAGEMENT GROUP, LLC 11/13/2024 0 $0   -100.00% 0.00%
SCIENTECH RESEARCH LLC 11/14/2024 0 $0   -100.00% 0.00%

Unicycive Therapeutics, Inc.institutional Ownership - Frequently Asked Questions

  • Who are the largest shareholders of UNCY shares?

    During the previous two years, 37 institutional investors and hedge funds held shares of Unicycive Therapeutics, Inc.. The most heavily invested institutionals were:

    Octagon Capital Advisors LP: 8.56 M

    GREAT POINT PARTNERS LLC: 8.56 M

    Logos Global Management LP: 5.08 M

    Walleye Capital LLC: 5 M

    Vivo Capital, LLC: 4.47 M

    SILVERARC CAPITAL MANAGEMENT, LLC: 4 M

  • What percentage of Unicycive Therapeutics, Inc. stock is owned by institutional investors?

    52.60% of Unicycive Therapeutics, Inc. stock is owned by institutional investors.

  • How much institutional buying is happening at UNCY ?

    Institutional investors have bought a total of 46.83 M shares in the last 24 months. This purchase volume represents approximately $33.25 M in transactions.